Idiopathic Hyperoxaluria
Showing 1 - 25 of 2,401
Hyperoxaluria, Nonalcoholic Fatty Liver Disease, Kidney Stone Trial in United States (BMN 255, Placebo)
Recruiting
- Hyperoxaluria
- +2 more
- BMN 255
- Placebo
-
Birmingham, Alabama
- +6 more
Nov 16, 2023
Prospective Research Rare Kidney Stones (ProRKS)
Recruiting
- Hyperoxaluria
- +4 more
-
Birmingham, Alabama
- +10 more
Nov 10, 2022
Cystinosis, Primary Hyperoxaluria Trial in Hanover (Diagnostic test)
Recruiting
- Cystinosis
- Primary Hyperoxaluria
- Diagnostic test
-
Hanover, Lower Saxony, GermanyScreening Laboratory Hanover
Apr 24, 2023
Healthy, Enteric Hyperoxaluria Trial in Cincinnati (FB-001, Placebo)
Recruiting
- Healthy
- Enteric Hyperoxaluria
- FB-001
- Placebo
-
Cincinnati, OhioMedpace Clinical Pharmacology Unit
Jan 23, 2023
Enteric Hyperoxaluria Trial in New York (Moderately High Oxalate (MOx) Diet)
Recruiting
- Enteric Hyperoxaluria
- Moderately High Oxalate (MOx) Diet
-
New York, New YorkNYU Langone Health
Nov 10, 2022
Thrombopoietin Agonists in Idiopathic Thrombocytopenic Purpura
Not yet recruiting
- ITP - Immune Thrombocytopenia
- eltrombopag and romiplastim
- (no location specified)
Nov 16, 2023
Primary Hyperoxaluria Type 1 (PH1) Trial in Worldwide (Placebo, Lumasiran)
Active, not recruiting
- Primary Hyperoxaluria Type 1 (PH1)
- Placebo
- Lumasiran
-
San Diego, California
- +15 more
Mar 4, 2022
Hyperoxaluria, Primary Trial in Worldwide (Oxabact OC5 - Oxalobacter formigenes Strain HC-1)
Terminated
- Hyperoxaluria, Primary
- Oxabact OC5 - Oxalobacter formigenes Strain HC-1
-
Nashville, Tennessee
- +7 more
Nov 11, 2021
Mortality of Rare Diseases in Taiwan With Real-world Evidence
Completed
- Rare Diseases
- +5 more
- longitudinal observational study
-
Tainan, TaiwanDepartment of Family Medicine, National Cheng Kung Univ Hosp
May 9, 2022
Idiopathic Pulmonary Hemosiderosis, Leflunomide Trial in Guangzhou (Leflunomide, Steroid Drug)
Recruiting
- Idiopathic Pulmonary Hemosiderosis
- Leflunomide
- Leflunomide
- Steroid Drug
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hospital of Sun Yat-sen University
Jun 30, 2023
Healthy Volunteers, Enteric Hyperoxaluria Trial in Canada, United States (combination product, biological, drug)
Recruiting
- Healthy Volunteers
- Enteric Hyperoxaluria
- NOV-001
- +3 more
-
Birmingham, Alabama
- +14 more
Jun 24, 2022
Primary Hyperoxaluria Trial in Bonn (Oxalobacter formigenes)
Completed
- Primary Hyperoxaluria
- Oxalobacter formigenes
-
Bonn, GermanyUniversitätsklinikum Bonn, Department of Paediatric Nephrology
Dec 9, 2021
Scoliosis Idiopathic, Scoliosis; Adolescence Trial (0.9% sodium chloride, Dexamethasone, Dexmedetomidine)
Not yet recruiting
- Scoliosis Idiopathic
- Scoliosis; Adolescence
- 0.9% sodium chloride
- +2 more
- (no location specified)
Oct 11, 2023
Idiopathic Inflammatory Myopathy, Dermatomyositis, Anti-Synthetase Syndrome Trial in Orange (CAB-201 following preconditioning
Recruiting
- Idiopathic Inflammatory Myopathy
- +3 more
- CAB-201 following preconditioning with fludarabine and cyclophosphamide
-
Orange, CaliforniaUniversity of California Irvine
Nov 30, 2023
Predictive Value of the PBS-score in Children With Clubfoot
Recruiting
- Clubfoot
- Systematic screening
-
Stockholm, Region Stockholm, SwedenAstrid Lindgren Children´s Hospital
Sep 17, 2023
Low Back Pain in Individuals With Idiopathic Scoliosis
Not yet recruiting
- Idiopathic Scoliosis
- Pain
-
Ankara, Altındağ, TurkeyHacettepe University, Institute of Health Sciences, Faculty of P
Sep 20, 2023
Idiopathic Short Stature Trial (diagnostic test, procedure, genetic)
Not yet recruiting
- Idiopathic Short Stature
- Evaluation of the prevalence of truly (authentified) idiopathic short stature after multidisciplinary clinico-radiological evaluation
- +2 more
- (no location specified)
May 4, 2023
Idiopathic Pulmonary Fibrosis Trial in Worldwide (BMS-986278, BMS-986278 Placebo)
Not yet recruiting
- Idiopathic Pulmonary Fibrosis
- BMS-986278
- BMS-986278 Placebo
-
Birmingham, Alabama
- +442 more
Aug 15, 2023
Pediatric Uveitis Patients
Not yet recruiting
- Uveitis
-
Assiut, Egypt
- +1 more
Oct 1, 2023
Glomerulonephritis, Membranous, Nephrotic Syndrome,Idiopathic Trial in Japan (Rituximab (genetical recombination), Placebo)
Not yet recruiting
- Glomerulonephritis, Membranous
- Nephrotic Syndrome，Idiopathic
- Rituximab (genetical recombination)
- Placebo
-
Anjo, Aichi, Japan
- +7 more
Jun 13, 2023
Description of Organizational Measures Framing Surgery for
Recruiting
- Practice Scope
- questionnaire on the organizational management
-
Saint-Étienne, FranceCHU Saint-Etienne
May 2, 2023
Idiopathic Hypersomnia Trial in United States (drug, diagnostic test, device)
Not yet recruiting
- Idiopathic Hypersomnia
- Low Sodium Oxybate
- +3 more
-
Phoenix, Arizona
- +3 more
Apr 19, 2023